Поражение нервной системы при СOVID-19
- Авторы: Белопасов В.В.1, Яшу Я.1, Самойлова Е.М.2, Баклаушев В.П.2
-
Учреждения:
- Астраханский государственный медицинский университет
- Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России
- Выпуск: Том 11, № 2 (2020)
- Страницы: 60-80
- Раздел: Научные обзоры
- URL: https://journals.rcsi.science/clinpractice/article/view/34851
- DOI: https://doi.org/10.17816/clinpract34851
- ID: 34851
Цитировать
Полный текст
Аннотация
В статье на основе имеющихся публикаций систематизированы сведения об основных формах поражения периферической и центральной нервной систем, их клинических проявлениях при СOVID-19. Обсуждаются методы диагностики (лабораторные, инструментальные и лучевые) и лечебная тактика при разных нозологических формах — от краниальных мононевропатий до острой воспалительной полинейропатии Гийена–Барре и тяжелых поражений головного и спинного мозга в виде острой геморрагической некротизирующей энцефалопатии и миелопатий. С точки зрения патогенеза, неврологические нарушения при COVID-19 могут быть обусловлены «цитокиновым штормом», гипоксемией, нарушениями гомеостаза (энцефалопатия критических состояний), нейротропностью и нейровирулентностью SARS-CoV-2 (изолированное поражение черепных нервов, очаговые и диффузные поражения ЦНС), а также смешанным воздействием перечисленных факторов. COVID-19 влияет на течение хронических неврологических заболеваний, особенно, связанных с нейроиммунными нарушениями. Все перечисленное определяет необходимость мультидисциплинарного подхода к лечению COVID-19 и его осложнений с обязательным участием специалиста-невролога.
Полный текст
Открыть статью на сайте журналаОб авторах
Владимир Викторович Белопасов
Астраханский государственный медицинский университет
Автор, ответственный за переписку.
Email: belopasov@yandex.ru
ORCID iD: 0000-0003-0458-0703
SPIN-код: 6089-1321
д.м.н., профессор
Россия, АстраханьЯссин Яшу
Астраханский государственный медицинский университет
Email: yassine.yachou@gmail.com
ORCID iD: 0000-0003-3173-3007
Student
Россия, АстраханьЕкатерина Михайловна Самойлова
Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России
Email: samoyket@gmail.com
ORCID iD: 0000-0002-0485-6581
SPIN-код: 3014-6243
научный сотрудник
Россия, МоскваВладимир Павлович Баклаушев
Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России
Email: baklaushev.vp@fnkc-fmba.ru
ORCID iD: 0000-0003-1039-4245
SPIN-код: 3968-2971
https://fnkc-fmba.ru/about/komanda-upravleniya/
Доктор медицинских наук, заместитель генерального директора по научной работе и мед. технологиям ФГБУ ФНКЦ ФМБА России
Россия, Москва
Список литературы
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. doi: 10.1001/jamaneurol.2020.1127.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
- Dalakas MC. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmu-ne neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e781. doi: 10.1212/NXI.0000000000000781.
- Sellner J, Taba P, Öztürk S, Helbok R. The need for neurologists in the care of COVID-19 patients. Eur J Neurol. 2020;10.1111/ene.14257. doi: 10.1111/ene.14257.
- Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618–1620. doi: 10.3201/eid2607.200445.
- Román GC, Spencer PS, Reis J, et al. The neurology of COVID-19 revisited: a proposal from the environmental neurology specialty group of the world federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. doi: 10.1016/j.jns.2020.116884.
- Sepehrinezhad A, Shahbazi A, Negah SS. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. J Neurovirol. 2020;26(3):324-329. doi: 10.1007/s13365-020-00851-2.
- Robinson CP, Busl KM. Neurologic manifestations of severe respiratory viral contagions. Crit Care Explor. 2020;2(4):e0107. doi: 10.1097/CCE.0000000000000107.
- Vonck K, Garrez I, De Herdt V, et al. Neurological manifestations and neuroinvasive mechanisms of the severe acute respiratory syndrome Coronavirus Type 2. Eur J Neurol. 2020;10.1111/ene.14329. doi: 10.1111/ene.14329.
- Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disea-se 2019 Pandemic: A Systemic Review. Front Neurol. 2020;11:498. doi: 10.33 9/fneur.2020.00 498.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.
- Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross sectional study. Clin Infect Dis. 2020;ciaa330. doi: https://doi.org/10.1093/cid/ciaa330.
- Liguori C, Pierantozzi M, Spanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;S0889-1591(20)30876-X. doi: 10.1016/j.bbi.2020.05.037.
- Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627. doi: 10.1016/S2215-0366(20)30203-0.
- Мосолов С.Н. Проблемы психического здоровья в условиях пандемии COVID-19 // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2020. — Т.120. — №5. — С. 7–15. [Mosolov SN. Problemy psikhicheskogo zdorov’ya v usloviyakh pandemii COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5):7–15. (In Russ).] https://doi.org/10.17116/jnevro20201200517
- Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34–39. doi: 10.1016/j.bbi.2020.04.027.
- Galea S, N. The mental health consequences of COVID-19 and physical distancing. The need for prevention and early intervention. JAMA Intern Med. 2020. doi: 10.1001/jamainternmed.2020.1562.
- Colizzi M, Bortoletto R, Silvestri M, Mondin F. Medically unexplained symptoms in the times of Covid-19 pandemic: A case-report. Brain Behav Immun Health. 2020;5:100073. doi: 10.1016/ j.bbih.2020.100073.
- Asadi-Pooya AA, Simani L.Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832.
- Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literatu-re review. J Clin Neurosci. 2020;77:8–12. doi: 10.1016/j.jocn.2020.05.017.
- Li Y, Wang M, Zhou Y, et al. Acute cerebrovascular disease following COVID-19: a single, retrospective, observational study. Lancet. 2020. doi: 10.2139/ssrn.3550025.
- Mahammedi A, Saba L, Vagal A, et al. Imaging in neurological disease of hospitalized COVID-19 patients. An Italian multicenter retrospective observational study. Radiology. 2020:201933. doi: 10.1148/radiol.2020201933.
- Guillan M, Villacieros-Alvarez J, Bellido S, Perez-Jorge Peremarch C. et al. Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient. J.Thromb Res. 2020 Jun 9;193:107-109. doi: 10.1016/j.thromres.2020.06.015
- Lu L, Xiong W, Liu D, Liu J. et al. Newonset acute symptomatic seizure and risk in Coronavirus Diseases 2019: A retrospective multicenter study. Epilepsia. 2020;61(6):e49–e53. doi: 10.1111/ epi.16524.
- Le Guennec L, Devianne J, Jalin L, Cao A, Galanaud D, Navarro V, Boutolleau D, Rohaut B, Weiss N, Demeret S. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020. doi: 10.1111/epi.16612.
- Fasano A, Cavallieri F, Canali E, Valzania F. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020:1-3. doi: 10.1007/s10072-020-04460.
- Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the Coronaviruses in the age of Coronavirus disease 2019: A review. JAMA Neurol. 2020. doi: 10.1001/jamaneurol.2020.2065.
- Elgamasy S, Kamel MG, Ghozy S, et al. First case of focal epilepsy associated with sars-coronavirus-2. J Med Virol. 2020;10.1002/jmv.26113. doi: 10.1002/jmv.26113.
- Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically Ill patients with COVID-19: Is there an association? Neurocrit Care. 2020;1–5. doi: 10.1007/s12028-020-01006-1.
- Kuroda N. Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav. 2020;108:107122. doi: 10.1016/j.yebeh.2020.107122.
- Карлов В.А., Бурд С.Г., Лебедева А.В., и др. Эпилепсия и COVID-19. Тактика и лечение. Рекомендации Российской противоэпилептической лиги // Эпилепсия и пароксизмальные состояния. — 2020. — Т.12. — №1. — С. 84–88. [Karlov VA, Burd SG, Lebedeva AV, et al. Epilepsy and COVID-19. Tactic and treatment. Recommendations of Russian League Against Epilepsy. Epilepsy and paroxysmal conditions. 2020;12(1):84–88. (In Russ).] doi: 10.17749/2077-8333.2020.12.1.84-88.
- Karimi N, Sharifi Razavi A, Rouhani N. Frequent convulsive seizures in an adult patient with COVID-19: A case report. Iran Red Crescent Med J. 2020;22(3):e102828. doi: 10.5812/ircmj.102828.
- Холин A.A., Заваденко Н.Н., Холина Е.A. Международные рекомендации по ведению пациентов с эпилепсией в условиях пандемии COVID-19 (по материалам ILAE) // РМЖ. Неврология. — 2020. — №8. — С. 2–4. [Kholin AA, Zavadenko NN, Kholina EA. Mezhdunarodnyye rekomendatsii po vedeniyu patsiyentov s epilepsiyey v usloviyakh pandemii COVID-19 (po materialam ILAE). Russian Medical Journal. 2020;(8):2–4. (In Russ).]
- Moriguchi T, Harii N, Goto J, et al. A first case of menin-getis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062.
- Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020;S0889-1591(20)30465-7. doi: 10.1016/j.bbi.2020.04.017.
- Bernard-Valnet R, Pizzarotti B, Anichini A, et al. Two patients with acute meningoencephalitis concomitant to SARS-CoV-2 infection. Eur J Neurol. 2020;10.1111/ene. doi: 10.1111/ene.14298.
- Dogan L, Kaya D, Sarikaya T, et al. Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series. Brain Behav Immun. 2020;87:155–158. doi: 10.1016/j.bbi.2020.05.022.
- Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early april 2020. Brain Behav Immun. 2020;7:33. doi: 10.1016/j.bbi.2020.04.024.
- Lovati C, Osio M, Pantoni L. Diagnosing Herpes simplex-1 Encephalitis at the Time of COVID-19 pandemic. Neurol Sci. 2020;41(6):1361–1364. doi: 10.1007/s10072-020-04461-y.
- Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020:382(17):1663–1665. doi: 10.1056/NEJMc2005073.
- McAbee GN, Brosqol Y, Pavlakis S, et al. Encephalitis assоciated with COVID-19 infection in 11 year-old child. Pediatric Neurology. 2020. doi: 10.1016/j.pediatrneurol.2020.04.013.
- Perchetti GA, Nalla AK, Huang M-L, et al.Validation of SARS-CoV-2 detection across multiple specimen types. J Clin Virol. 2020;128:104438. doi: 10.1016/j.jcv.2020.104438.
- Al-Olama M, Rashid A, Garozzo D. COVID-19-associated Meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir (Wien). 2020;162(7):1495–1499. doi: 10.1007/s00701-020-04402-w.
- Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424. doi: 10.1084/jem.20050828.
- Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other Coronaviruses. Brain Behav Immun. 2020;87:18–22. doi: 10.1016/j.bbi.2020.03.031.
- Hung EC, Chim SS, Chan PK, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109. doi: 10.1373/clinchem.2003.025437.
- Zhang QL, Ding YQ, Hou JL, et al. Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization. Di Yi Jun Yi Da Xue Xue Bao. 2003;23(11):1125–1127.
- Pilotto A, Odolini S, Masciocchi SS, et al. Steroid-responsive Encephalitis in Covid-19 disease. Ann Neurol. 2020;10.1002/ana.25783. doi: 10.1002/ana.25783.
- Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory Coronaviruses. J Virol. 2000;74(19):8913–8921. doi: 10.1128/jvi.74.19.8913-8921.2000.
- Lau K-K, Yu W-C, Chu C-M, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342–344. doi: 10.3201/eid1002.030638.
- Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14(3):113–119.
- Panariello A, Bassetti R, Radice A, et al. Anti-NMDA receptor encepha-litis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun. 2020;87:179–181. doi: 10.1016/j.bbi.2020.05.054.
- Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel Coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020;92(7):786–790. doi: 10.1002/jmv.25918.
- Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0.
- Hoshino A, Saitoh M, Oka A, et al. Epidemiology of acute ence-phalopathy in japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2012;34(5):337–343. doi: 10.1016/j.braindev.2011.07.012.
- Bohmwald K, Galvez N, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386. doi: 10.3389/fncel.2018.00386.
- Чучин М.Ю. Острая некротическая энцефалопатия при вирусной инфекции // Детская больница. — 2012. — №1. — С. 23–28. [Chuchin MYu. Acute necrotizing encephalopathy after viral infection. Detskaya bol’nitsa. 2012;(1):23–28. (In Russ).]
- Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and otherviral infections. Acta Neurol Scand. 2007;115(4Suppl):45–56. doi: 10.1111/1600-0404.2007.00809.x.
- Araujo R, Gouveia P, Fineza I. Bilateral thalamic lesions in acute necrotizing encepha-lopathy due to H1N1 infection visual diagnosis. Pediatr Neurol. 2016;65:96–97. doi: 10.1016/j.pediatrneurol.2016.08.008.
- Meijer WJ, Linn FH, Wensing AM, et al. Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Reports. 2016;3(6):e005076. doi: 10.1099/jmmcr.0.005076.
- Иванова Г.П. Лейкоэнцефалиты у детей: дифференциально-диагностические, патогенетические и терапевтические аспекты: Автореф. дис. … докт. мед. наук. — СПб., 2012. — 44 с. [Ivanova GP. Leykoentsefality u detey: differentsial’no-diagnosticheskiye, patogeneticheskiye i terapevticheskiye aspekty. [dissertation abstract] Saint Petersburg; 2012. 44 р. (In Russ).] Доступно по: https://search.rsl.ru/ru/record/01005012368. Ссылка активна на 14.02.2020.
- Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14. doi: 10.3390/v12010014.
- Das G, Mukherjee N, Ghosh S. Neurological insights of COVID-19 pandemic. ACS Chem Neurosci. 2020:11(9):1206–1209. doi: 10.1021/acschemneuro.0c00201.
- Dixon L, Varley J, Gontsarova A, Mallon D, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e789. doi: 10.1212/NXI.0000000000000789.
- Cardona GC, Quintana Pájaro LD, Quintero Marzola GC, et al. Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci. 2020;412:116824. doi: 10.1016/j.jns.2020.116824.
- Radmanesh A, Derman A, Lui YW, et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;202040. doi: 10.11-48/radiol.2020202040.
- Kandemirli SG, Dogan L, Sarikaya ZT, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;201697. doi: 10.1148/radiol.2020201697.
- Novi G, Rossi T, Pedemonte E, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e797. doi: 10.1212/NXI.0000000000000797.
- Parsons T, Banks S, Bae C, et al. COVID-19-associated Acute Disseminated Encephalomyelitis (ADEM). J Neurol. 2020;1–4. doi: 10.1007/s00415-020-09951-9.
- Reichard RR, Kashani KB, Boire NA, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1–6. doi: 10.1007/s00401-020-02166-2.
- Franceschi AM, Ahmed O, Giliberto L, Castillo M. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol. 2020. doi: 10.3174/ajnr.A6595.
- Byrnes S, Bisen M, Syed B, et al. COVID-19 Encephalopathy masquerading as substance withdrawal. J Med Virol. 2020;10.1002/jmv.26065. doi: 10.1002/jmv.26065.
- Pastor J, Vega-Zelaya L, Abad EM. Specific EEG encephalopathy pattern in SARS-CoV-2 patients. J Clin Med. 2020;9(5):E1545. doi: 10.3390/jcm9051545.
- Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;20118. doi: 10.1148/radiol.2020201187.
- Цинзерлинг В.А., Чухловина М.Л. Инфекционные поражения нервной системы: вопросы этиологии, патогенеза и диагностики. Руководство для врачей. — СПб.: ЭЛБИ-СПб, 2011. — 584 с. [Tsinzerling VA, Chukhlovina ML. Infektsionnyye porazheniya nervnoy sistemy: voprosy etiologii, patogeneza i diagnostiki. Rukovodstvo dlya vrachey. Saint Petersburg: ELBI-SPb; 2011. 584 р. (In Russ).]
- Шмидт Т.Е. Редкие демиелинизирующие заболевания центральной нервной системы // Неврологический журнал. — 2016. — Т.21. — №5. — С. 252–264. [Shmidt TE. Rare demyelinating diseases of central nervous system. Nevrologicheskiy Zhurnal (Neurological Journal). 2016;21(5):252–264. (In Russ).] doi: 10.18821/1560-9545-2016-21-5-252-264.
- Radmanesh F, Rodriguez-Pla A, Pincus MD, Burns JD. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis. J Clin Neurosci. 2020;76:236–237. doi: 10.1016/j.jocn.2020.04.054.
- Finelli PF, Uphoff DF. Magnetic resonance imaging abnormalities with septic encephalopathy. J Neurol Neurosurg Psychiatry. 2004;75(8):1189–1191. doi: 10.1136/jnnp.2003.030833.
- Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55. doi: 10.3389/fimmu.2019.00055.
- Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists’ perspective on coronavi rus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020;39(7):2055–2062. doi: 10.1007/s10067-020-05073-9.
- Valade S, Azoulay E, Galicier L, et al. Coagulation disorders and bleedings in critically ill patients with hemophagocytic lymphohistiocytosis. Mediсine. 2015;94(40):e1692. doi: 10.1097/MD.0000000000001692.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi: 10.1001/jama ophthalmol.2020.1291.
- Loon SC, Teoh SC, Oon LL, et al. The severe acute respiratory syndrome Coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi: 10.1136/bjo.2003.035931.
- Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis. Clin Ter. 2020;171(3):e189–e191. doi: 10.7417/CT.2020.2212.
- Баклаушев В.П., Кулемзин С.В., Горчаков А.А., и др. COVID-19. Этиология, патогенез, диагностика и лечение // Клиническая практика. — 2020. — Т.11. — №1. — С. 7–20. [Baklaushev VP, Kulemzin SV, Gorchakov АА, et al. COVID-19. Etiology, pathogenesis, diagnosis and treatment. Journal of Clinical Practice. 2020;11(1):7–20. (In Russ).] doi: 10.17816/clinpract26339.
- Li JО, Lam DS, Chen Y, Ting DS. Novel Coronavirus disease 2019 (COVID-19): the importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020;104(3):297–298. doi: 10.1136/bjophthalmol-2020-315994.
- Chen Lu, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–755. doi: 10.1136/bjophthalmol-2020-316304.
- Vassilara F, Spyridaki A, Pothitos G, et al. A rare case of human coronavirus 229E associated with acute respiratory distress syndrome in a healthy adult. Case Rep Infect Dis. 2018;2018:6796839. doi: 10.1155/2018/6796839.
- Zhou Y, Zeng Y, Tong Y, et al. Ophthalmologic evidence against the interpersonal trans-mission of 2019 novel coronavirus through conjunctiva. New York: medRxiv. 2020. doi: 10.1101/2020.02.11.20021956.
- Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi: 10.1016/j.idcr.2020.e00774.
- Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;S0008-4182(20)30305-7. doi: 10.1016/j.jcjo.2020.03.003.
- Sadhu S, Agrawal R, Pyare R, et al. COVID-19: Limiting the risks for eye care professionals. Ocul Immunol Inflamm. 2020;1–7. doi: 10.1080/0927394-8.2020.1755-442.
- De Grootmijnes JD, van Dun JM, van der Most RG, de Groot RJ. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J Virol. 2005;79(2):1036–1044. doi: 10.1128/JVI.79.2.1036-1044.2005.
- Neri P, Pichi F. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol. 2020;40(5):1057–1060. doi: 10.1007/s10792-020-01389-2.
- Nakagaki K, Nakagaki K, Taguchi F. Receptor-independent spread of a highly neurotropic murine coronavirus JHMV strain from initially infected microglial cells in mixed neural cultures. J Virol. 2005;79(10):6102–6110. doi: 10.1128/JVI.79.10.6102-6110.2005.
- Shindler KS, Kenyon LC, Dutt M, et al. Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. J Virol. 2008;82(17):8882–8886. doi: 10.1128/JVI.00920-08.
- Bailey OT, Pappenheimer AM, Cheever FS, Daniels JB. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: II. Pathology. J Exp Med. 1949;90(3):195–212. doi: 10.1084/jem.90.3.195.
- Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of Coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi: 10.1080/09273948.2020.1738501.
- Butowt R, Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. 2020;11(9):1200–1203. doi: 10.1021/acschemneuro.0c00172.
- Qing H, Li Z, Yang Z, et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. 2020;98(3):e388. doi: 10.1111/aos.14412.
- Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: A cross-sectional study. Clin Infect Dis. 2020;ciaa330. doi: 10.1093/cid/ciaa330.
- Ralli M, Di Stadio A, Greco A, et al. Defining the burden of olfactory dysfunction in COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020;24(7):3440–3441. doi: 10.26355/eurrev_202004_20797.
- Lechien JR, Chiesa-Estomba CM, Place S, et al.; COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate Coronavirus Disease 2019. J Intern Med. 2020;10.1111/joim.13089. doi: 10.1111/joim.13089.
- Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020;S1473-3099(20)30293-0. doi: 10.1016/S1473-3099(20)30293-0.
- Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58(3):299–301. doi: 10.4193/Rhin20.114.
- Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 2020;58(3):295–298. doi: 10.4193/Rhin20.116.
- Moein ST, Hashemian SM, Mansourafshar B, et al. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10.1002/alr.22587. doi: 10.1002/alr.22587.
- Yan CH, Faraji F, Prajapati DP, et al. Association of chemosen-sory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10.1002/alr.22579. doi: 10.1002/alr.22579.
- Gautier J-F, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity (Silver Spring). 2020;28(5):848. doi: 10.1002/oby.22809.
- Izquierdo-Dominguez A, Rojas-Lechuga MJ, Mullol J, Alobid I. Olfactory dysfunction in the COVID-19 outbreak. J Investig Allergol Clin Immunol. 2020. doi: 10.18176/jiaci.0567.
- Temmel AF, Quint C, Schickinger-Fischer B, et al. Characteristics of olfactory dis-orders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;128(6):635–641. doi: 10.1001/archotol.128.6.635.
- Soler ZM, Patel ZM, Turner JH, Holbrook EH. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol. 2020;10.1002/alr.22578. doi: 10.1002/alr.22578.
- Lovato A, de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. 2020;145561320920762. doi: 10.1177/0145561320920762.
- Heidari F, Karimi E, Firouzifar M, et al. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58(3):302–303. doi: 10.4193/Rhin20.140.
- Obiefuna S, Donohoe C. Neuroanatomy, Nucleus Gustatory. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
- Goh Y, Beh DL, Makmur A, et al. Pearls and oysters: facial nerve palsy as a neurological manifestation of Covid-19 infection. Neurology. 2020;10.1212/WNL.0000000000009863. doi: 10.1212/WNL.0000000000009863.
- Andorinho de Freitas Ferreira AC, Romão ТТ, Macedo YS, et al. COVID-19 and herpes zoster coinfection presenting with trigeminal neuropathy. Eur J Neurol. 2020:10.1111/ene.14361. doi: 10.1111/ene.14361.
- Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130(7):1787. doi: 10.1002/lary.28692.
- Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42(6):1252–1258. doi: 10.1002/hed.26204.
- Finsterer J, Stollberger C. Causes of Hypogeusia/Hyposmia in SARS-CoV2 infected patients. J Med Virol. 2020;10.1002/jmv.25903. doi: 10.1002/jmv.25903.
- Wee LE, Chan YF, Teo NW, et al. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19. Eur Arch Otorhinolaryngol. 2020;1–2. doi: 10.1007/s00405-020-05999-5.
- Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. 2020;69(6):973–974. doi: 10.1136/gutjnl-2020-321195.
- Agarwal A, Chen A, Ravindran N, et al. Gastrointestinal and liver manifestations of COVID-19. J Clin Exp Hepatol. 2020;10(3):263–265. doi: 10.1016/j.jceh. 2020.03.001.
- Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi: 10.1056/NEJMc2001468.
- Collins AM, Neurogenic Cough. Neurologic and Neurodegenerative Diseases of the Larynx. 2020. Р. 253—261.
- Татарников В.С. Роль ростральных вентролатеральных отделов продолговатого мозга в регуляции активности дыхательного центра: Автореф. дис. … канд. мед. наук. — Самара, 1996. — 22 с. [Tatarnikov VS. Rol’ rostral’nykh ventrolateral’nykh otdelov prodolgovatogo mozga v regulyatsii aktivnosti dykhatel’nogo tsentra. [dissertation abstract] Samara; 1996. 22 р. (In Russ).] Доступно по: https://search.rsl.ru/ru/record/01000098524. Ссылка активна на 14.02.2020.
- Lee I-C, Huo T-I, Huang Yi-H. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc. 2020;10.1097/JCMA.0000000000000319. doi: 10.1097/jcma.0000000000000319.
- Shastin D, Nidamanuri P, Nannapaneni R. Recurrent hiccups may signal brainstem pathology and should be investigated. BMJ Case Rep. 2018;2018. pii: bcr-2017-222926. doi: 10.1136/bcr-2017-222926.
- Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41(8):1089–1096. doi: 10.1086/444461.
- Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host‐virus interaction, and proposed neurotropic mechanisms. ACS Chem Neursci. 2020;11(7):995–998. doi: 10.1021/acschemneuro.0c00122.
- Li Y‐C, Bai W‐Z, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol. 2020;92(6):552–555. doi: 10.1002/jmv.25728.
- Tassorelli C, Mojoli F, Baldanti F, et al. COVID-19: What if the brain had a role in causing the deaths? Eur J Neurol. 2020;10.1111/ene.14275. doi: 10.1111/ene.14275.
- McCray PB, L, C, et al. Lethal infection of K18-hACE2 Mice infected with severe acute respiratory syndrome Coronavirus. . 2007;81(2):813–821. doi: .
- Natoli S, Oliveira V, Calabresi P, et al. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020;10.1111/ene.14277. doi: 10.1111/ene.14277.
- Camdessanche JP, Morel J, Pozzetto B, et al. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020;176(6):516–518. doi: 10.1016/j.neurol.2020.04.003.
- Riva N, Russo T, Falzone YM, et al. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report. J Neurol. 2020;1–3. doi: 10.1007/s00415-020-09907-z.
- Alberti P, Beretta S, Piatti M, et al. Guillain-Barré Syndrome Related to COVID-19 Infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e741. doi: 10.1212/XI.0000000000000741.
- Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576. doi: 10.1056/NEJMc2009191.
- Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? J Neurol. 2020;1–3. doi: 10.1007/s00415-020-09849-6.
- Finsterer J, Scorza FA, Ghosh R. COVID-19 Polyradiculitis in 24 Patients Without SARS-CoV-2 in the Cerebro-Spinal Fluid. J Med Virol. 2020;10.1002/jmv.26121. doi: 10.1002/jmv.26121.
- Coen M, Jeanson G, Almeida LA, et al. Guillain-Barré Syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. 2020;87:111–112. doi: 10.1016/j.bbi.2020.04.074.
- Lascano AM, Epiney J-B, Coen M, et al. SARS-CoV-2 and Guillain-Barré Syndrome: AIDP variant with favorable outcome. Eur J Neurol. 2020;10.1111/ene.14368. doi: 10.1111/ene.14368.
- Bigaut K, Mallaret M, Baloglu S, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. doi: 10.1212/NXI.0000000000000785.
- Assini A, Benedetti L, Di Maio S, et al. New clinical manifestation of COVID-19 related Guillain-Barrè Syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020. doi: 10.1007/s10072-020-04484-5.
- Oguz-Akarsu E, Ozpar R, Mirzayev H, et al. Guillain-Barré syndrome in a patient with minimal symptoms of COVID-19 infection. Muscle Nerve. 2020;10.1002/mus.26992. doi: 10.1002/mus.26992.
- Sedaghat Z, Karimi N. Guillain-Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233–235. doi: 10.1016/j.jocn.2020.04.062.
- El Otmani H, El Moutawakil B, Rafai MA, et al. Covid-19 and Guillain-Barré syndrome: more than a coincidence! Rev Neurol (Paris). 2020;176(6):518–519. doi: 10.1016/j.neurol.2020.04.007.
- Su XW, Palka SV, Rao RR, et al. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve. 2020;10.1002/mus.26988. doi: 10.1002/mus.26988.
- Turgay C, Emine T, Ozlem K, et al. A rare cause of acute flaccid paralysis: human coronaviruses. J Pediatr Neurosci. 2015;10(3):280–281. doi: 10.4103/1817-1745.165716.
- Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol. 2017;13(3):227–233. doi: 10.3988/jcn.2017.13.3.227.
- Gigli GL, Bax F, Marini A, et al. Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2020;1–3. doi: 10.1007/s00415-020-09911-3.
- Gupta A, Paliwal VK, Garg RK. Is COVID-19-related Guillain-Barré syndrome different? Brain Behav Immun. 2020;87:177–178. doi: 10.1016/j.bbi.2020.05.051.
- Sancho-Saldaña A, Lambea-Gil Á, Capablo Liesa JL, et al. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Med (Lond). 2020;clinmed.2020-0213. doi: 10.7861/clinmed.2020-0213.
- Chan JL, Ebadi H, Sarna JR. Guillain-Barré syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci. 2020;1–10. doi: 10.1017/cjn.2020.106.
- Caamaño DS, Beato AR. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020;77:230–232. doi: 10.1016/j.jocn.2020.05.016.
- Helbok R, Beer R, Löscher W, et al. Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2. Eur J Neurol. 2020. doi: 10.1111/ene.14388.
- Scoppetta C, Di Gennaro G, Polverino F. Editorial – High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020;24(9):5178–5179. doi: 10.26355/eurrev_202005_21214.
- Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller fisher syndrome and polyneuritis Cranialis in COVID-19. Neurology. 2020;10.1212/WNL.0000000000009619. doi: 10.1212/WNL.0000000000009619.
- Lantos JE, Strauss SB, Lin E. COVID-19-associated miller fisher syndrome: MRI findings. AJNR Am J Neuroradiol. 2020. doi: 10.3174 /ajnr.A6609.
- Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;10.1212/WNL.0000000000009700. doi: 10.1212/WNL.0000000000009700.
- Wei H, Yin H, Huang M, Guo Z. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267(5):1550–1553. doi: 10.1007/s00415-020-09773-9.
- Pérez Álvarez ÁI, Suárez Cuervo C, Fernández Menéndez S. [Infección por SARS-CoV-2 asociada a diplopía y anticuerpos antirreceptor de acetilcolina. (In English, Spanish)]. Neurología. 2020,35(4):264–265. doi: 10.1016/j.nrl.2020.04.003.
- Anand P, Slama MC, Kaku M, et al. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020;10.1002/mus.26918. doi: 10.1002/mus.26918.
- Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959–969. doi: 10.1212/WNL.0000000000009566.
- Jacob S, Muppidi S, Guidon A, et al; International MG/COVID-19 Working Group. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020;412:116803. doi: 10.1016/j.jns.2020.116803.
- Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci. 2020;414:116888. doi: 10.1016/j.jns.2020.116888.
- Ramaswamy SB, Govindarajan R. COVID-19 in Refractory Myasthenia Gravis - A Case Report of Successful Outcome. J Neuromuscul Dis. 2020;7(3):361-364. doi: 10.3233/JND – 200520.
- Wong PF, Craik S, Newman P, et al. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond). 2020. pii: clinmed.2020-0182. doi: 10.7861/clinmed.2020-0182.
- Cuneo GL, Grazzini I, Guadagni M, et al. An atypical Bickerstaff’s brainstem encephalitis with involvement of spinal cord. Neuroradiol J. 2016;29(5):396–399. doi: 10.1177/197140091666 5383.
- Муртазина А.Ф., Наумова Е.С., Никитин С.С., и др. Стволовой энцефалит Бикерстаффа, острый поперечный миелит и острая моторная аксональная нейропатия: сложности диагностики и лечения пациентов с перекрестными синдромами. Клиническое наблюдение // Нервно-мышечные болезни. — 2017. — Т.7. — №3. — С. 56–62. [Murtazina AF, Naumova ES, Nikitin SS, et al. Bickerstaff brainstem encephalitis, acute transverse myelitis, and acute motor axonal neuropathy: diagnostic and treatment challenges in patients with concomitant syndromes. Clinical observation. Neuromuscular Diseases. 2017;7(3):56–62. (In Russ).] doi: 10.17650/2222-8721-2017-7-3-56-62.
- Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e803. doi: 10.1212/NXI.0000000000000803.
- Гусев Е.И., Мартынов М.Ю., Бойко А.Н., и др. Новая коронавирусная инфекция (COVID-19) и поражение нервной системы: механизмы неврологических расстройств, клинические проявления, организация неврологической помощи // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2020. — Т.120. — №6. — С. 7–16. [Gusev EI, Martynov MYu, Boyko AN, et al. Novaya koronavirusnaya infektsiya (COVID-19) i porazheniye nervnoy sistemy: mekhanizmy nevrologicheskikh rasstroystv, klinicheskiye proyavleniya, organizatsiya nevrologicheskoy pomoshchi. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):7–16. (In Russ).] doi: 10.17116/ jnevro20201200617. https://doi.org/10.17116/jnevro20201200617
- Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Федерация анестезиологов и реаниматологов. Методические рекомендации. — М., 2020. — 183 с. [Anesteziologo-reanimatsionnoye obespecheniye patsiyentov s novoy koronavirusnoy infektsiyey COVID-19. Federatsiya anesteziologov i reanimatologov. Metodicheskiye rekomendatsii. Moscow; 2020. 183 p. (In Russ).]
- Lai C-C, Liu YH, Wang C-Yi, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53(3):404–412. doi: 10.1016/j.jmii.2020.02.012.
- Varga Z, Flammer AJ, Steiger P, et al. Endotehelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi: 10.1016/S0140-6736 (20)30937-5.
- Morassi M, Bagatto D, Cobelli M, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020;1–8. doi: 10.1007/s00415-020-09885-2.
- Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. doi: 10.1001/jama-cardio.2020.1096.
- Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020:e201017.doi: 10.1001/jamacardio.2020.1017.
- Qureshi AI, Abd-Allah F, Alsenani F, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. Int J Stroke. 2020;1747493020923234. doi: 10.1177/1747493020923234.
- Pranata R, Huang I, Lukito AA, Raharjo SB. Elevated N-terminal Pro-Brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020;96(1137):387–391. doi: 10.1136/postgradmedj-2020-137884.
- Tu WJ, Cao J, Yu L, et al. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan. Intensive Care Med. 2020;46(6):1117–1120. doi: 10.1007/s00134-020-06023-4.
- Madjid M, Safavi‐Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. doi: 10.1001/jamacardio.2020.1286.
- Akhmerov A, Marban E. COVID-19 and the heart. Circ Res. 2020;126(10):1443–1455. doi: 10.1161/CIRCRES AHA.120.317055.
- Aggarwal G, Lippi G, Henry BM. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020;15(4):385–389. doi: 10.1177/1747493020921664.
- Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. 2020;11(3):322–325. doi: 10.1007/s12975-020-00818-9.
- Young K. COVID-19: Stroke in Young Adults/New Presentation in Kids/ACS Advissions. N Engl J Med. 2020. doi: 10.1056/NEYMc2009787.
- Jin H., Hong C., Chen S., Zhou Y , Wang Y. et al. Consensus for Prevention and Management of Coronavirus Disease 2019 (COVID-19) for Neurologists. Stroke Vasc. Neurol., 2020; svn-2020-0003-82. doi: 10.1136/svn-2020-000382.
- Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024.
- Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi: 10.1056/NEJMc2007575.
- Bernstein L, Stead Sellers F. Patients with heart attacks, strokes and even appendicitis vanish from hospitals. 2020. Available from: https://www.washingtonpost.com/health/patients-with-heart-attacks-strokes-and-even-appendicitis-vanish-from-hospitals/2020/04/19/9ca3ef24-7eb4-11ea-9040-68981f488eed_story.html.
- Cavalcanti DD, Raz E, Shapiro M, et al. Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol. 2020. doi: 10.3174/ajnr.A6644.
- Hughes C, Nichols T, Pike А, et al. Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med. 2020;7(5):001691. doi: 10.12890/2020_001691.
- Poillon G, Obadia M, Perrin M, et al. Cerebral venous thrombosis associated with COVID-19 infection: causality or coincidence? J Neuroradiol. 2020;S0150-9861(20)30167-X. doi: 10.1016/j.neu-rad.2020.05.003.
- Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115–119. doi: 10.1016/j.bbi.2020.04.077.
- Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and antithrom-botic treatment in Coronavirus 2019: a new challenge. Thromb Haemost. 2020;120(6):949–956. doi: 10.1055/s-0040-1710317.
- Zhao J, Rudd A, Liu R. Challenges and potential solutions of stroke care during the Coronavirus disease 2019 (COVID-19) outbreak. Stroke. 2020;51(5):1356–1357. doi: 10.1161/STROKEAHA.120.029701.
- Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi: 10.1056/NEJMc2009787.
- Siniscalchi A, Gallelli L. Could COVID-19 represent a negative prognostic factor in patients with stroke? Infect Control Hosp Epidemiol. 2020;1. doi: 10.1017/ice.2020.146.
- Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. doi: 10.1056/NEJMc2008597.
- Dafer RM, Osteraas ND, Biller J. Acute stroke care in the Coronavirus disease 2019 pandemic. J Stroke Cerebrovasc Dis. 2020;29(7):10488. doi: 16/j.jstrokecerebrovasdis.2020.104881.
- Leira EC, Russman AN, Biller J, et al. Preserving stroke care during the COVID-19 pandemic: potential issues and solutions. Neurology. 2020;10.1212/WNL.00000-00000009713. doi: 10.1212/WNL.0000000000009713.
- Tsivgoulis G, Palaiodimou L, Katsanos AH, et al. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. 2020;13:1756286420932036. doi: 10.1177/1756286420932036
- Smith MS, Bonomo J, Knight 4th WA, et al. Endovascular therapy for patients with acute ischemic stroke during the COVID-19 Pandemic: a proposed algorithm. Stroke. 2020;51(6):1902–1909. doi: 10.1161/STROKEAHA.120.029863.
- Fraser JF, Arthur AS, Chen M, et al. Society of neurointerventional surgery recommendations for the care of emergent neurointerventional patients in the setting of Covid-19. J Neurointerv Surg. 2020;12(6):539–541. doi: 10.1136/neu-rintsurg-2020-016098.
- Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. doi: 10.1016/j.nmni.2020.100669.
- Saiegh FA, Ghosh R, Leibold A, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;jnnp-2020-323522. doi: 10.1136/jnnp-2020-323522.
- Chougar L., Mathon B., Weiss N., Degos V., Shor N. Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19. AJNR Am J Neuroradiol. 2020. doi: 10.3174/ajnr.A6642.
- Herman C., Mayer K., Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology., 2020; 95:1-8. doi: 10.1212/WNL.0000000000 009673.
- Tay HS, Harwood R. Atypical presentation of COVID-19 in a frail older person. Age Ageing. 2020;afaa068. doi: 10.1093/ageing/afaa068.
- Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;e200950. doi: 10.1001/jamacardio.2020.0950.
- Potere N, Valeriani E, Candeloro M, Tana M, Porreca E. et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care. 2020;24(1):389. doi: 10.1186/s13054-020-03022-1.
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–448. doi: 10.1016/S2213-2600(20)30079-5.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
- La Hue SC, James TC, Newman JC, et al. W. Collaborative Delirium Prevention in the Age of COVID-19. J Am Geriatr Soc. 2020;68(5):947–949. doi: 10.1111/jgs.16480.
- Sanders BJ, Bakar M, Mehta S, et al. Hyperactive delirium requires more aggressive management in patients with COVID-19: temporarily rethinking “Low and Slow”. J Pain Symptom Manage. 2020: S0885-3924(20)30389-4. doi: 10.1016/j.jpainsymman.2020.05.013.
- Salluh JI, Wang H, Schneider EB. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ. 2015;350:h2538. doi: 10.1136/bmj.h2538.
- O’Hanlon S, Inouye SK. Delirium: a missing piece in the COVID-19 pandemic puzzle. Age Ageing. 2020:afaa094. doi: 10.1093/ageing/afaa094.
- Alkeridy WA, Almaghlouth I, Alrashed R, et al. A unique presentation of delirium in a patient with otherwise asymptomatic COVID-19. J Am Geriatr Soc. 2020;10.1111/jgs.16536. doi: 10.1111/jgs.16536.
- Kotfis K, Roberson SW, Wilson JE, et al. COVID-19: ICU delirium management during SARS-CoV-2.pandemic.Crit Care. 2020;24(1):176. doi: 10.1186/s13054-020-02882-x.
- Седация пациентов в отделениях анестезиологии, реанимации и интенсивной терапии. Федерация анестезиологов и реаниматологов. Методические рекомендации. — М., 2020. — 39 с. [Sedatsiya patsiyentov v otdeleniyakh anesteziologii, reanimatsii i intensivnoy terapii. Federatsiya anesteziologov i reanimatologov. Metodicheskiye rekomendatsii. Moscow; 2020. 39 p. (In Russ).]
- Kotfis K, Williams RS, Wilson J, et al. COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic? Anaesthesiol Intensive Ther. 2020;40590. doi: 10.5114/ait.2020.95164.
- Shneider A, Kudriavtsev A, Vakhrusheva A. Can Melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020;1–10. doi: 10.1080/08830185.2020.1756284.
- Zambrelli E, Canevini M, Gambini O, D’Agostino A. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? Sleep Med. 2020;70:111. doi: 10.1016/j.sleep.2020.04.006.
- Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, et al. Genera-lized myoclonus in COVID-19. Neurology. 2020;10.1212/WNL.0000000000009829. doi: 10.1212/WNL.00000 00000009829.
- Balloy G., Mahé P.J., Leclair-Visonneau L., Péréon Y. et al. Non-lesional status epilepticus in a patient with coronavirus disease 2019. Neurophysiol., 2020.doi: 10.1016/j.clinph.2020. 05.005.
- Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2020. doi: 10.1002/jmv.26207.
- Asadi-Pooya A.A. Seizures Associated With Coronavirus Infections. Seizure., 2020;79:49-52. doi: 10.1016/j.seizure.2020.05.005.
- French JA, Brodie MJ, Caraballo R. Keeping people with epilepsy safe during the Covid-19 pandemic. Neurology. 2020;94(23):1032–1037. doi: 10.1212/WNL0000000000009632.
- Zayet S, Abdallah YB, Royer P-Y, et al. Encephalopathy in patients with COVID-19: ‘Causality or Coincidence?’ J Med Virol. 2020;10.1002/jmv.26027. doi: 10.1002/jmv.26027.
- Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of Coronavirus disease (COVID-19) Encephalopathy. Cureus. 2020;12(3):e7352. doi: 10.7759/cureus.7352.
- Haddad S, Tayyar R, Risch L, et al. Encephalopathy and Seizure Activity in a COVID-19 well controlled HIV patient. IDCases. 2020;21:e00814.doi: 10.1016/j.idcr.2020.e00814.
- Pinto AA, Carroll LS, Nar V, et al. CNS inflammatory vasculopathy with Antimyelin Oligodendrocyte Glycoprotein Antibodies in COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e813. doi: 10.1212/NXI.0000000000000813.
- Brun G, Hak J-F, Coze S, et al. COVID-19-White matter and globus pallidum lesions: demyelination or small-vessel vasculitis? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e777. doi: 10.1212/NXI.0000000000000777.
- Zanin L, Saraceno G, Panciani PP, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien). 2020;162(7):1491–1494. doi: 1007/s00701-020-04374-x.
- Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C. et al. Pathological Findings of COVID-19 Associated With Acute Respiratory Distress Syndrome. Lancet Respir. Med., 2020;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X.
- Li Z, Huang Y, Guo X. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion. Sci China Life Sci. 2020;63(5):771–773. doi: 10.1007/s11427-020-1690-y.
- Colafrancesco S., Alessandri C., Conti F., Priori R. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmun. Rev., 2020 :102573. doi: 10.1016/ j. autrev.2020.102573.
- Лунева И.Е., Полищук Р.В., Чернобаева Л.С., и др. Острый некротический энцефалит, ассоциированный с вирусом гриппа, у взрослых // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2020. — Т.120. — №4. — С. 102–106. [Luneva IE, Polishchuk RV, Chernobayeva LS, et al. Ostryy nekroticheskiy entsefalit, assotsiirovannyy s virusom grippa, u vzroslykh. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(4):102–106. (In Russ).] doi: 10.17116/jnevro2020120041102.
- Мартынов М.Ю., Шамалов Н.А., Хасанова Д.Р., и др. Ведение пациентов с острыми нарушениями мозгового кровообращения в контексте пандемии COVID-19. Временные методические рекомендации. Версия 2.16.04. — М., 2020. — 18 с. [Martynov MYu, Shamalov NA, Khasanova DR, et al. Vedeniye patsiyentov s ostrymi narusheniyami mozgovogo krovoobrashcheniya v kontekste pandemii COVID-19. Vremennyye metodicheskiye rekomendatsii. Version 2.16.04. Moscow; 2020. 18 p. (In Russ).]
- Berger JR, Brandstadter R, Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e761. doi: 10.1212/NXI.0000000000000761.
- Kandasamy M. Perspectives for the Use of Therapeutic Botulinum Toxin as a multifaceted candi-date drug to attenuate COVID-19. Med Drug Discov. 2020;6:100042. doi: 10.1016/j.medidd. 2020.100042.
- Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. Exp Med. 2020;217(6):e20200652. doi: 10.1084/jem.20200652.
- Пастер Л. Избранные труды в 2 т. Т. I / Под ред. А.А. Имшенецкого. — М.: Издательство Академии Наук СССР, 1960. — 1012 с. [Paster L. Izbrannyye trudy v 2 t. Vol. I. Ed by A.A. Imshenetsky. Moscow: Izdatel’stvo Akademii Nauk SSSR; 1960. 1012 p. (In Russ).]
- Xu H., Zhong L., Deng J. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. doi: 10.1038/s41368-020-0074-x.
- Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. bioRxiv. 2020;2020.03.25.009084. doi: 10.1101/2020.03.25.009084.
- Vavougios G.D. Host Proteases as Determinants of Coronaviral Neurotropism and Virulence. Brain Behav. Immun., 2020;S0889-1591(20)30464-5. doi: 10.1016/j.bbi.2020.04.010.
- Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv. 2020. doi: 10.1101/2020.01.26.919985.
- Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020;323(23):2427–2429. doi: 10.1001/jama.2020.8707.
- Gandhi S., Srivastava A. K., Ray U., Tripathi P.P. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? ACS Chem Neuro- sci. 2020;11(10):1379-1381. doi: 10.1021/acschemneuro.0c00217.
- Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;1–6. doi: 10.1007/s00415-020-09929-7.
- Le Сoupanec A, Desforges M, Meessen-Рinard M, et al. Cleavage of a neuroinvasive human respiratory virus spike glycoprotein by proprotein convertases modulates neurovirulence and virus spread within the central nervous system. PLoS Pathog. 2015;11(11):e1005261. doi: 10.1371/journal.ppat.1005261.
- Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory Syndrome Coronavirus-2 (SARS-CoV-2). J MedVirol. 2020;92(7):699–702. doi: 10.1002/ jmv.25915.
- Lau K.-K., Yu W.-C., Chu C.-M., Lau S.-T., Sheng B., Yuen K.-Y. Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis., 2004;10(2):342-344.doi:10.32 01/eid1002.030638.
- Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7275. doi: 10.1128/JVI.00737-08.
- Dubé M, Le Coupanec A, Wong AH, et al. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00-404-18. doi: 10.1128/JVI.00404-18.
- Perlman S, Evans G, Afifi A. Effect of olfactory bulb ablation on spread of a neurotropic corona-virus into the mouse brain. J Exp Med. 1990;172(4):1127–1132. doi: 10.1084/jem.172.4.1127.
- Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;1–5. doi: 10.1007/s10072-020-04486-3.
- Singh AK, Bhushan B, Maurya A, et al. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders. Dermatol Ther. 2020;e13591. doi: 10.1111/dth.13591.
- Mori I. Transolfactory neuroinvasion by viruses threatens the human brain. Acta Virol. 2015;59(4):338–349. doi: 10.4149/av_2015_04_338.
- Beghi E, Feigin V, Caso V, Santalucia P, Logroscino G. COVID-19 Infection and Neurological Complications: Present Findings and Future Predictions. Neuroepidemiology. 2020 Jul 1:1-6. doi: 10.1159/000508991.
- Wang L, Shen Y, Li M, et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. 2020;1–13. doi: 10.1007/s00415-020-09974-2.
- Yachou Y, El Idrissi A, Belopasov V, et al. Neuroinvasion, neurotropic and neuroinflam-matory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020.
- Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1–11. doi: 10.1002/ana.25807.
- Kwong KC, Mehta PR, Shukla G, Mehta AR. COVID-19, SARS and MERS: a neurological perspective COVID-19, SARS and MERS: a neurological perspective. J Clin Neurosci. 2020;77:13–16. doi: 10.1016/j.jocn.2020.04.124.
- Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22. doi: 10.1111/ane.13266.
- Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R . Unraveling the mystery of Covid-19 Cytokine storm: From skin to organ systems. Dermatol Ther. 2020 Jun 19:e13859. doi: 10.1111/dth.13859.
- Bridwell R., Long B., Gottlieb M. Neurologic Complications of COVID-19. Am. J. Emerg. Med,. 2020. doi: 10. 1016/j.ajem.2020.05.024.
- Baig AM. Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement. ACS Chem Neurosci. 2020;11(9):1204–1205. doi: 10.1021/acschem neuro.0c00181.
- Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘cytokine storm’ in COVID-19. J Infect. 2020;80(6):607–613. doi: 10.1016/j.jinf.2020.03.037.
- Chigr F, Merzouki M, Najimi M. Autonomic Brain Centers and Pathophysiology of COVID-19. ACS Chem Neurosci. 2020;11(11):1520-1522. doi: 10.1021/acschem neuro.0с00265.
- Li K, Wohlford‐Lenane C, Perlman S, et al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712‐722. doi: 10.1093/infdis/jiv499.
- Li Z, Huang Y, Guo X. The Brain, Another Potential Target Organ, Needs Early Protection From SARS-CoV-2 Neuroinvasion. Sci. China Life Sci. 2020;63(5):771-773. doi: 10.1007/s11427-020-1690-y.
- Neilson DE, Adams MD, Orr CMD, Schelling DK, Eiben RM et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009; 84:44–51. doi: 10.1016/j. ajhg.2008.12.009.
- Singh R.R., Sedani S., Lim M., Wassmer E., Absoud M. RANBP2 Mutation and Acute Necro-tizing Encephalopathy: 2 Cases and a Literature Review of the Expanding Clinico-Radiological Phenotype. Eur. J. Paediatr. Neurol., 2015;19(2):106-13. doi: 10.1016/j. ejpn.2014.11.010.
- Cappello F. COVID-19 and molecular mimicry: The Columbus’ egg? J Clin Neurosci. 2020;77:246. doi: 10.1016/j.jocn.2020.05.015.
- Lippi A, Domingues R, Setz C, et al. SARS-CoV-2: at the crossroad between aging and neurodegeneration. Mov Disord. 2020;35(5):716–720. doi: 10.1002/mds.28084.
- Papa SM, Brundin P, Fung VS, et al. Impact of the COVID-19 pandemic on parkinson’s disease and movement disorders. Mov Disord. 2020;35(5):711–715. doi: 10.1002/mds.28067.
- Бойко А.Н., Лащ Н.Ю., Спирин Н.Н., и др. Ведение пациентов с рассеянным склерозом в условиях пандемии COVID-19. Временные методические рекомендации. Версия 1.19.04. — М., 2020. — 12 с. [Boyko AN, Lashch NYu, Spirin NN, et al. Vedeniye patsiyentov s rasseyannym sklerozom v usloviyakh pandemii COVID-19. Vremennyye metodicheskiye rekomendatsii. Version 1.19.04. Moscow; 2020. 12 p. (In Russ).].
- Rajabally YA., Goedee HS., Attarian S., Hartung H-P. Management Challenges for Chronic Dysimmune Neuropathies During the COVID-19 Pandemic. Muscle Nerve., 2020;10.1002/ mus. 26896. doi: 10.1002/mus.26896.
- Robertson MM, Eapen V, Rizzo R, et al. Gilles de la tourette syndrome: advice in the times of COVID-19. F1000Res. 2020;9:257. doi: 10.12688/f1000 research.23-275.2.
- Копишинская С. В., Жаринова Н. О., Величко И. А. и др. Основные принципы ведения неврологических пациентов в период пандемии COVID-19. Нервно-мышечные болезни 2020; 10(1):31–42. DOI: 10.17650 /2222-8721-2020 – 10 – 1 – 31 – 42.
- Moro E. , Deuschl G., de Visser M. , Muresanu D. et al. A Call From the European Academy of Neurology on COVID-19. Lancet Neurol., 2020; 19(6):482. doi:10.1016/ S1474-4422(20)30151-4.
- Needham EJ., Chou S. H-Y., Coles A.J., Menon D19 Infections. Neurocrit. Care., 2020; K Neurological Implications of COVID-1919 Infections. Neurocrit. Care., 2020; 1-5. doi: 10.1007/s tions of COVID-19 Infections. Neurocrit. Care., 2020; 1-5. doi: 10.1007/s12028.
- https://isaric.tghn.org/covid-19-clinical-research-resources/. COVID-19 Rapid Evidence ReviewsGroup.